Weave Communications (NYSE: WEAV) FY Conference Summary Industry Overview - Weave operates in the SMB healthcare sector, providing communication engagement software primarily for dental, optometry, veterinary, and specialty medical practices [4][10]. Core Points and Arguments 1. **AI Integration**: Weave is focusing on integrating AI into its workflows to enhance relevance in the healthcare sector. This includes automating appointment scheduling and payment collections, which are critical for practice growth and efficiency [4][5][12]. 2. **Market Demand**: SMB healthcare practices are primarily concerned with growing their practice, improving payment efficiency, and increasing profitability. Weave's solutions aim to address these needs through AI-driven automation [4][5]. 3. **Differentiation from Competitors**: Weave emphasizes its deep understanding of the healthcare industry, which allows it to effectively integrate with practice management systems. This is a significant advantage over horizontal AI tools that may not grasp the industry's nuances [7][8]. 4. **Adoption Rates**: There is a broad willingness to adopt AI across different healthcare sectors, but the pace varies. Dental practices, particularly those part of larger organizations, are leading in AI adoption compared to smaller, single-practitioner medical practices [9][10]. 5. **Total Addressable Market (TAM)**: Weave estimates a $3 billion TAM expansion related to scheduling solutions alone, indicating significant growth potential as more workflows are automated [12][13]. 6. **Market Penetration**: Weave has penetrated 10% to 15% of its mature verticals like dental and optometry, suggesting ample room for growth, especially in mid-market segments and specialty medical practices [14][15][20]. 7. **Future Growth Drivers**: Key growth areas include expanding into specialty medical, enhancing payment solutions, and leveraging AI for operational efficiency. The company aims to double its Annual Recurring Revenue (ARR) to $500 million, with operating margins projected between 15% to 20% [18][20][21]. 8. **Capital Allocation**: Weave has over $75 million in cash and is open to strategic acquisitions that align with its growth strategy, particularly those that enhance its capabilities and customer offerings [16][17]. Additional Important Insights 1. **Omnichannel Communication**: The future of AI in Weave's strategy includes developing omnichannel agents that can manage interactions across various platforms, enhancing patient engagement [28][29]. 2. **Customer Experience**: Weave is focused on creating a unified inbox for practices, allowing them to manage all patient interactions in one place, which is expected to significantly improve operational efficiency [28][29]. 3. **Internal AI Initiatives**: Weave is exploring AI applications internally, particularly in customer support and finance, to enhance operational efficiency and decision-making [25][26]. This summary encapsulates the key insights from Weave Communications' FY conference, highlighting the company's strategic focus on AI integration, market opportunities, and growth potential within the SMB healthcare sector.

Financial Data and Key Metrics Changes - Weave reported revenue of $58.5 million for Q2 2025, reflecting a 15.6% year-over-year growth and marking the fourteenth consecutive quarter of exceeding revenue guidance [5][19] - Gross margin improved to 72.3%, up 40 basis points year-over-year and 20 basis points quarter-over-quarter [21] - Free cash flow for the quarter was $4.5 million, indicating strong cash flow performance [6][24] Business Line Data and Key Metrics Changes - The acquisition of TrueLark contributed to revenue and expenses, with over one month of TrueLark's financials included in Q2 results [19] - Gross revenue retention for Q2 was 90%, with net revenue retention at 96%, consistent with historical performance [20] - Specialty medical has become the second largest vertical by customer count, with significant growth in medical aesthetics, primary care, and physical therapy [13] Market Data and Key Metrics Changes - Weave's solutions are increasingly critical for small and medium-sized healthcare practices, with 96% reporting a growing patient base [6] - The company is expanding its reach through authorized integrations with various electronic medical record systems, enhancing patient engagement [14] Company Strategy and Development Direction - Weave aims to position itself as the go-to platform for healthcare practices by integrating AI-powered workflow solutions and enhancing operational efficiency [12] - The company is focused on mid-market partnerships and specialty medical growth initiatives, with targeted investments to drive these areas [22] Management's Comments on Operating Environment and Future Outlook - Management noted that operational efficiency is a key growth lever amid labor constraints and inflationary pressures [7] - The outlook for 2025 anticipates revenue growth in the range of $236.8 million to $239.8 million, with profitability expected to improve in the second half of the year [25] Other Important Information - The company has made significant progress in integrating TrueLark, with joint selling initiatives already underway [18][42] - Weave ranked first in 34 categories in G2's summer 2025 report, reflecting strong customer trust and satisfaction [15] Q&A Session Summary Question: What commonality is seen in specialty medical success? - Management highlighted focus areas such as medical aesthetics and physical therapy, noting that initial average selling prices (ASP) are lower but expected to rise as brand recognition grows [30][32] Question: How has the growth of payments compared to subscriptions? - Payments continue to grow faster than subscriptions, with an increased attach rate within the installed base [36] Question: What is the status of TrueLark integration? - Integration activities are ongoing, with joint prospecting and sales efforts already in place [41][42] Question: What are the dynamics of customer acquisition costs (CAC) in the enterprise push? - CAC for the mid-market team is favorable, with a strong pipeline being built [48] Question: What opportunities exist for price increases? - Price increases will be evaluated on a cohort basis, especially as product value increases [87] Question: How is Call Intelligence adoption progressing? - Call Intelligence is making progress, with ongoing efforts to identify new workflows for customer use [90]

Weave Overview Q2 2025 NYSE : WEAV JULY 2025 These factors, together with those described in greater detail in our Annual Report on Form 10-K that we filed with the Securities and Exchange Commission ("SEC") on March 13, 2025, may cause our actual results, performance or achievements to differ materially and adversely from those anticipated or implied by our forward-looking statements. All forward-looking statements herein reflect our opinions only as of the date of this presentation, and we undertake no ob ...

Weave Overview Q1 2025 NYSE : WEAV MAY 2025 1 Safe Harbor Statement This presentation has been prepared by Weave Communications, Inc. ("Weave", "we", "us", or "our") for informational purposes only and not for any other purpose. This presentation contains "forward-looking statements" within the Private Securities Litigation Reform Act of 1995 that are based on our management's current expectations and projections about future events and financial trends that we believe may affect our financial condition, re ...